这种情况在慢性粒细胞白血病中尤为常见。
Which is precisely what happens in the case of chronic myelogenous leukaemia.
慢性粒细胞白血病的治疗方法有哪些?。
慢性粒细胞白血病进行骨髓移植手术成功率？
Does leukaemia of chronic bead cell undertake medullary transplanting operation is led successfully?
慢性粒细胞性白血病的症状和体征往往发展缓慢。
是否有必要杀死最后的慢性粒细胞白血病细胞？
目的观察阻变灵胶囊治疗慢性粒细胞白血病的疗效。
Objective: TO observe the effect of Zubianling capsule in treating chronic myeloid leukemia.
目的探讨HA方案治疗慢性粒细胞白血病急性变的疗效。
Objective To explore the curative effect of HA schemes on chronic granulocytic leukemia during the period of acute exacerbation.
目的了解祛毒化瘀中药复方治疗慢性粒细胞白血病的作用机制。
Objective To study the mechanism of traditional Chinese medicine compound of Qudu Huayu Formula on Chronic Myelocytic Leukemia (CML).
目的：了解慢性粒细胞白血病（CML）患者的血脂变化规律。
Objective:In order to know the alternation of plasma lipids in chronic myelogenous leukemia(CML).
慢性粒细胞白血病CML是造血干细胞的恶性克隆增生性疾病。
Chronic myelocytic leukemia (CML) is the malignant clone disease which occurs in a haematopoietic stem cell.
bcrabl；酪氨酸激酶；抑制剂；慢性粒细胞白血病；综述。
BCRABL; tyrosine kinases; inhibitors; chronic myelogenous leukemia; review.
目的：检测慢性粒细胞白血病（CML）患者血清IL-18水平。
Objective To measure the serum level of interleukin-18(IL-18) in patients with chronic myelocytic leukemia (CML).
P 53基因失活与慢性粒细胞白血病的急变、病情进展密切相关。
The inactivation of P53 is associated with the acute transformation phase and development of CML.
慢性粒细胞白血病是一种造血干细胞克隆性增殖所致的骨髓增殖性疾病。
Chronic myelocytic leukemia is a clonal proliferation of hematopoietic stem cells caused by myeloproliferative disorders.
此方法是当前检测慢性粒细胞性白血病残留细胞较灵敏、较可靠的方法。
This method is proved to be sensitive and reliable for detecting residual cells of CML.
慢性粒细胞白血病(CML)的PK活性增高，而PK同工酶型均正常。
PK activity was increased in CML, while the PK isoenzyme pattern was normal.
总结分析以清肝化瘀法为主治疗慢性粒细胞白血病5 2例的远期疗效。
To summarize and analyze curative effect on 52 cases of Chronic Myelogenous Leukemia (CML) by clearing away liver fire and dispersing blood stasis.
目的探讨JWA基因表达与慢性粒细胞性白血病（CML）的相关意义。
Objective The purpose of this study is to find the relationship and significance between the expression of JWA gene and chronic myelogenous leukemia (CML).
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
相关疾病还有一些不涉及BCR-ABL基因的其它类型的慢性粒细胞白血病。
There are other types of CML that do not involve the BCR-ABL gene.
同时，在慢性粒细胞白血病治疗方面，另两个采用类似基因治疗的研究也收获成果。
Two other studies, meanwhile, confirmed that a similar approach to chronic myelogenous leukaemia continues to bear fruit.
目的对慢性粒细胞白血病患者进行健康教育，提高患者的自我保健能力和生活质量。
Objective to carry out health education of patients with chronic myelogenous leukemia to improve patients self - conservancy and life quality.
当前治疗对一些慢性粒细胞白血病病人无效，医生正在研究其他可能有所帮助的药物。
Doctors are studying other drugs that may help CML patients who do not respond to current treatment.
目的为了解慢性粒细胞白血病（CML）骨髓中巨核细胞和网状纤维的增生情况及其关系。
Objective To determine the distribution of reticulin fibre and megakaryocyte in bone marrow biopsy(Trephine biopsy)of chronic myelogenous leukemia (CML).
有些病人在常规体检的血液检查后才知道他们患有慢性淋巴细胞白血病或慢性粒细胞性白血病。
Some patients learn they have CLL or CML after a blood test as part of a regular checkup.
目的：探讨慢性粒细胞白血病（CML）患者BCR/ABL融合基因表达与中医辨证分型的关系。
Objective:To study on relationship between of BCR/ABL fusion gene expression and TCM syndrome classification in the patient of chronic myelogenous leukemia(CML).
此外，还对部分配合物进行体外抗癌活性测试研究，实验靶细胞是人慢性粒细胞性白血病K562细胞。
The research showed that the complexes can inhibit K562 tumor cell's growth, generation and induce apoptosis.
此外，还对部分配合物进行体外抗癌活性测试研究，实验靶细胞是人慢性粒细胞性白血病K562细胞。
The research showed that the complexes can inhibit K562 tumor cell's growth, generation and induce apoptosis.
应用推荐